Literature DB >> 10464155

Angiotensin II receptor antagonists in the pharmacological therapy of portal hypertension: a caution.

G García-Tsao.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10464155     DOI： 10.1016/s0016-5085(99)70472-5

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  4 in total

Review 1.  Angiotensin converting enzyme inhibitors and angiotensin II antagonists as therapy in chronic liver disease.

Authors:  J Vlachogiannakos; A K Tang; D Patch; A K Burroughs
Journal:  Gut       Date:  2001-08       Impact factor: 23.059

2.  Does angiotensin II type 1 receptor blockade offer a clinical advantage to cirrhotics with ascites?

Authors:  Hiroshi Fukui
Journal:  J Gastroenterol       Date:  2002       Impact factor: 7.527

Review 3.  The hepatorenal syndrome.

Authors:  L Dagher; K Moore
Journal:  Gut       Date:  2001-11       Impact factor: 23.059

4.  Pathogenetic background for treatment of ascites and hepatorenal syndrome.

Authors:  Søren Møller; Jens H Henriksen; Flemming Bendtsen
Journal:  Hepatol Int       Date:  2008-09-20       Impact factor: 6.047
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.